Cargando…
HIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patients
BACKGROUND: HIV-associated general immune activation is a strong predictor for HIV disease progression, suggesting that chronic immune activation may drive HIV pathogenesis. Consequently, immunomodulating agents may decelerate HIV disease progression. METHODS: In an observational study, we determine...
Autores principales: | Kasang, Christa, Ulmer, Albrecht, Donhauser, Norbert, Schmidt, Barbara, Stich, August, Klinker, Hartwig, Kalluvya, Samuel, Koutsilieri, Eleni, Rethwilm, Axel, Scheller, Carsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3282641/ https://www.ncbi.nlm.nih.gov/pubmed/22264238 http://dx.doi.org/10.1186/1471-2334-12-14 |
Ejemplares similares
-
Effects of Prednisolone on Disease Progression in Antiretroviral-Untreated HIV Infection: A 2-Year Randomized, Double-Blind Placebo-Controlled Clinical Trial
por: Kasang, Christa, et al.
Publicado: (2016) -
HIV Drug Resistance (HIVDR) in Antiretroviral Therapy-Naïve Patients in Tanzania Not Eligible for WHO Threshold HIVDR Survey Is Dramatically High
por: Kasang, Christa, et al.
Publicado: (2011) -
Plasma Concentrations of Efavirenz and Nevirapine among HIV-Infected Patients with Immunological Failure Attending a Tertiary Hospital in North-Western Tanzania
por: Gunda, Daniel W., et al.
Publicado: (2013) -
Prevalence of chronic HBV infection in pregnant woman attending antenatal care in a tertiary hospital in Mwanza, Tanzania: a cross-sectional study
por: Geffert, Karin, et al.
Publicado: (2020) -
The effects of opioids on HIV reactivation in latently-infected T-lymphoblasts
por: Prottengeier, Johannes, et al.
Publicado: (2014)